Literature DB >> 8806530

Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase.

G R Simpson1, C Patience, R Löwer, R R Tönjes, H D Moore, R A Weiss, M T Boyd.   

Abstract

All primates studied to date produce retroviral-like particles in their placentae. We have purified these particles from two primate species, one Old World (human) and one New World (marmoset), and have identified the retroviral sequences which are packaged into these particles. Three families of sequences have been detected in these particles in human, all of which have the highest homology to B- and D-type retroviruses and to the human endogenous retrovirus HERV-K10. Previous studies have reported that the New World monkeys do not possess sequences with homology to HERV-K10. We have identified a new family of low-copy-number sequences which are present in New World monkeys and which possess 70% homology to the HERV-K family. Particles from both species possess reverse transcriptase activity and we have found that some of these retroviral particles package sequences which encode long open reading frames in pol, as revealed by expression cloning in Escherichia coli. These open reading frames could encode the reverse transcriptase enzyme activity found in the particles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806530     DOI: 10.1006/viro.1996.0443

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.

Authors:  B Berkhout; M Jebbink; J Zsíros
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

2.  ERV3 and related sequences in humans: structure and RNA expression.

Authors:  Ann-Catrin Andersson; Zhihong Yun; Göran O Sperber; Erik Larsson; Jonas Blomberg
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Genome-wide amplification of proviral sequences reveals new polymorphic HERV-K(HML-2) proviruses in humans and chimpanzees that are absent from genome assemblies.

Authors:  Catriona M Macfarlane; Richard M Badge
Journal:  Retrovirology       Date:  2015-04-28       Impact factor: 4.602

4.  Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice.

Authors:  A E Casau; J E Vaughan; G Lozano; A J Levine
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  A novel exogenous retrovirus sequence identified in humans.

Authors:  D J Griffiths; P J Venables; R A Weiss; M T Boyd
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.

Authors:  C Patience; Y Takeuchi; F L Cosset; R A Weiss
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.

Authors:  Aashish R Jha; Satish K Pillai; Vanessa A York; Elizabeth R Sharp; Emily C Storm; Douglas J Wachter; Jeffrey N Martin; Steven G Deeks; Michael G Rosenberg; Douglas F Nixon; Keith E Garrison
Journal:  Mol Biol Evol       Date:  2009-08-10       Impact factor: 16.240

Review 8.  Retroelements and the human genome: new perspectives on an old relation.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

9.  Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.

Authors:  Lindsey R Robinson; Sean P J Whelan
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

10.  Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Philippe Leissner; Thibault Verjat; Ilaria Ferlenghi; Fabio Bagnoli; Fabiola Giusti; Michael H Dosik; Daniel F Hayes; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.